Chromium picolinate/cinnamon Interactions
There are 79 drugs known to interact with chromium picolinate/cinnamon, along with 2 disease interactions. Of the total drug interactions, 79 are moderate.
- View all 79 medications that may interact with chromium picolinate/cinnamon
- View chromium picolinate/cinnamon disease interactions (2)
Most frequently checked interactions
View interaction reports for chromium picolinate / cinnamon and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Align (bifidobacterium infantis)
- Allegra (fexofenadine)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Centrum Silver Women's (multivitamin with minerals)
- Coenzyme Q10 (ubiquinone)
- CoQ10 (ubiquinone)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Januvia (sitagliptin)
- Jardiance (empagliflozin)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Ozempic (semaglutide)
- Paxlovid (nirmatrelvir / ritonavir)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Rybelsus (semaglutide)
- Singulair (montelukast)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zinc (zinc sulfate)
- Zyrtec (cetirizine)
Chromium picolinate/cinnamon disease interactions
There are 2 disease interactions with chromium picolinate / cinnamon which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.